Publication | Open Access

Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein?based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia

VaccinationCervical CancerVaccine DevelopmentHuman Papillomavirus VaccinesImmunologyPathologyVirologyPhase I/ii TrialPublic HealthHuman PapillomavirusMedicinePrecancerous LesionsE7 ProteinCancer-associated Virus